Answers are grounded in this paper and cite their sources.
This study demonstrates the synthesis of zirconia nanoparticles using Terminalia catappa extract, showing enhanced antibacterial and anticancer activities.
Zirconia nanoparticles (ZrO₂ NPs) are eco-friendly and biocompatible materials used for various biological applications. Herein, we reported Terminalia catappa (T. catappa) fallen leaves extract encapsulated ZrO₂ NPs without using a chemical reducing agent. The bandgap, absorption, functional groups, and crystalline structure were identified using a UV-Visible spectrophotometer (UV-Vis), a Fourier transform infrared spectrometer (FT-IR), and an X-ray diffractometer. The transmission electron microscope (TEM) images confirmed the formation of spherical particles with an average size of 6 nm. The absorption in the range of 299-307 nm confirmed the formation of ZrO₂ NPs. The stretching vibration bands at 467 and 621 cm⁻¹ confirmed the presence of the Zr-O-Zr bond in ZrO₂ NPs. According to the X-ray diffraction pattern (XRD), the average crystallite size of the ZrO₂ NPs was 4 nm with a cubic structure. The nanoparticles Zr0.01, Zr0.02, and Zr0.03 exhibited 26, 28, and 32 mm zones of inhibition against Lactobacillus acidophilus, Staphylococcus albus, and Streptococcus mutans at a maximum concentration of 25µg/ml. The ZrO₂ exhibited an IC₅₀ value of ZrO₂ to be 32.63 μg/mL against A549 cell lines. Therefore, biogenic T. catappa extract-encapsulated zirconia nanoparticles can be used for the development of potential antibacterial and anticancer agents.
No takes yet. Share an insight, caveat, or question.
Suresh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: